全文获取类型
收费全文 | 40821篇 |
免费 | 3899篇 |
国内免费 | 103篇 |
专业分类
耳鼻咽喉 | 399篇 |
儿科学 | 1082篇 |
妇产科学 | 885篇 |
基础医学 | 5851篇 |
口腔科学 | 608篇 |
临床医学 | 4465篇 |
内科学 | 8156篇 |
皮肤病学 | 525篇 |
神经病学 | 3876篇 |
特种医学 | 1015篇 |
外国民族医学 | 4篇 |
外科学 | 5588篇 |
综合类 | 843篇 |
一般理论 | 51篇 |
预防医学 | 3934篇 |
眼科学 | 1102篇 |
药学 | 3566篇 |
中国医学 | 56篇 |
肿瘤学 | 2817篇 |
出版年
2023年 | 226篇 |
2022年 | 301篇 |
2021年 | 829篇 |
2020年 | 525篇 |
2019年 | 835篇 |
2018年 | 900篇 |
2017年 | 652篇 |
2016年 | 782篇 |
2015年 | 889篇 |
2014年 | 1260篇 |
2013年 | 1784篇 |
2012年 | 2568篇 |
2011年 | 2701篇 |
2010年 | 1518篇 |
2009年 | 1361篇 |
2008年 | 2315篇 |
2007年 | 2441篇 |
2006年 | 2475篇 |
2005年 | 2452篇 |
2004年 | 2376篇 |
2003年 | 2101篇 |
2002年 | 2001篇 |
2001年 | 721篇 |
2000年 | 619篇 |
1999年 | 644篇 |
1998年 | 501篇 |
1997年 | 452篇 |
1996年 | 423篇 |
1995年 | 409篇 |
1994年 | 341篇 |
1993年 | 344篇 |
1992年 | 544篇 |
1991年 | 457篇 |
1990年 | 404篇 |
1989年 | 384篇 |
1988年 | 429篇 |
1987年 | 375篇 |
1986年 | 337篇 |
1985年 | 300篇 |
1984年 | 342篇 |
1983年 | 287篇 |
1982年 | 266篇 |
1981年 | 229篇 |
1980年 | 200篇 |
1979年 | 241篇 |
1978年 | 179篇 |
1977年 | 166篇 |
1976年 | 183篇 |
1975年 | 168篇 |
1974年 | 174篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Michael W. Manning Yi-Ju Li Dean Linder John C. Haney Yi-Hung Wu Mihai V. Podgoreanu Madhav Swaminathan Jacob N. Schroder Carmelo A. Milano Ian J. Welsby Mark Stafford-Smith Kamrouz Ghadimi 《Journal of cardiothoracic and vascular anesthesia》2021,35(5):1310-1318
- Download : Download high-res image (215KB)
- Download : Download full-size image
12.
13.
14.
15.
16.
Prevalence of Potentially Inappropriate Prescribing Among Hong Kong Older Adults: A Comparison of the Beers 2003, Beers 2012, and Screening Tool of Older Person's Prescriptions and Screening Tool to Alert doctors to Right Treatment Criteria
下载免费PDF全文
![点击此处可从《Journal of the American Geriatrics Society》网站下载免费的PDF全文](/ch/ext_images/free.gif)
17.
Stanislas Grassin‐Delyle Michaela Semeraro Frantz Foissac Naim Bouazza Haleema Shakur‐Still Ian Roberts Jean‐Marc Treluyer Saïk Urien 《Fundamental & clinical pharmacology》2019,33(6):670-678
Tranexamic acid (TXA) is an antifibrinolytic drug that reduces surgical blood loss and death due to bleeding after trauma and post‐partum haemorrhage. One key issue for treatment success is early administration. While usually given intravenously, oral and intramuscular use would be useful in specific circumstances. Therefore, an understanding of TXA pharmacokinetics when given via different routes is valuable. The aim of this study was to perform an individual participant data meta‐analysis of pharmacokinetic studies with TXA given to healthy volunteers via different routes. We searched the following databases: PubMed, Web of Science, Wiley Online Library, Elsevier Science Direct and J‐STAGE. Individual subject data were extracted when available, otherwise arithmetic means were used. A population pharmacokinetic model was developed using nonlinear mixed effect modelling. Seven studies were included in the analysis with data from 10 patients for the IV route, six patients for the IM route and 114 patients for the oral route. The pharmacokinetics was ascribed to a two‐compartment model, and the main covariate was allometrically scaled bodyweight. Oral and IM bioavailabilities were 46 and 105%, respectively. For a 70 kg bodyweight, the population estimates were 7.6 L/h for clearance, 17.9 L for the volume of the central compartment, 2.5 L/h for the diffusional clearance and 16.6 L for the peripheral volume of distribution. Larger well‐designed studies are needed to describe the pharmacokinetics of TXA when given IM or as an oral solution before these can be recommended as alternatives to IV. 相似文献
18.
BACKGROUND: Posterior spinal procedures through tubular exposures have been described. However, tubes restrain visibility and require co-axial instrument manipulation, increasing difficulty and potentially compromising surgical results. An independent-blade retractor system overcomes the obstacles of working through a tube and has been used to perform minimally-disruptive decompression and instrumented tranforaminal lumbar interbody fusion (TLIF). PURPOSE: To evaluate the advantages to patient recovery and surgical efficacy of this technique. METHODS/RESULTS: Retrospective review of technique employing a minimally-disruptive approach to decompression and transforaminal lumber interbody fusion (TLIF). CONCLUSIONS: Minimally-disruptive decompression and instrumented TLIF can be performed in a safe and effective manner using an independent-blade retractor system. Relative to traditional-open techniques, surgical goals can be accomplished, but with the benefits of minimally-disruptive surgery. 相似文献
19.
Eduardo Krajewski Ian S Soriano Jorge Ortiz 《JSLS, Journal of the Society of Laparoendoscopic Surgeons》2006,10(4):426-431
BACKGROUND: Solid-organ transplantation has become the treatment of choice for patients with end-stage renal disease, end-stage liver failure, and some patients with type 1 diabetes mellitus. Similarly, surgical expertise and mechanical improvements have led to significant advances in laparoscopic surgery. Laparoscopic interventions are sometimes not pursued in transplant recipients due to the lack of strong supporting evidence for the use of laparoscopic techniques in these patients. METHODS: Using an extensive literature search, we review herein the available data on the utility of laparoscopic interventions in transplant recipients, with particular attention to the risks and benefits, indications, and contraindications for this complex patient population. RESULTS: Although randomized trials are few, multiple case reports indicate that many transplant recipients have benefited from laparoscopic interventions. CONCLUSION: The well-known benefits of laparoscopy could be extended to transplant recipients. 相似文献
20.
Targeted silencing of disease-associated genes by synthetic short interfering RNA (siRNA) holds considerable promise as a novel therapeutic strategy. However, unmodified siRNA can be potent triggers of the innate immune response, particularly when associated with delivery vehicles that facilitate intracellular uptake. This represents a significant barrier to the therapeutic development of siRNA due to toxicity and off-target gene effects associated with this inflammatory response. Here we show that immune stimulation by synthetic siRNA can be completely abrogated by selective incorporation of 2'-O-methyl (2'OMe) uridine or guanosine nucleosides into one strand of the siRNA duplex. These noninflammatory siRNA, containing less than 20% modified nucleotides, can be readily generated without disrupting their gene-silencing activity. We show that, coupled with an effective systemic delivery vehicle, 2'OMe-modified siRNA targeting apolipoprotein B (apoB) can mediate potent silencing of its target mRNA, causing significant decreases in serum apoB and cholesterol. This is achieved at therapeutically viable siRNA doses without cytokine induction, toxicity, or off-target effects associated with the use of unmodified siRNA. This approach to siRNA design and delivery should prove widely applicable and represents an important step in advancing synthetic siRNA into a broad range of therapeutic areas. 相似文献